Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments like off-the-shelf CAR T. The Company is headquartered in Paris, France, at Paris Biotech Santé.
| Website | http://www.smart-immune.com |
| Employees | 12 (9 on RocketReach) |
| Founded | 2017 |
| Address | Paris Biotech santé - Pole innovation 29, Rue du Faubourg Saint-Jacques, Paris, Île-de-France 75014, FR |
| Industry | Biotechnology Research, Biotechnology, Drug Discovery |
| Keywords | T Cell Therapy, Immunotherapy, Cell Therapy, Immune System, Cancer Treatment, Cancer Research, Oncology, Immunology, Infection Treatment, Biotechnology, Drug Development, Clinical Stage, Regenerative Medicine, Pharmaceutical, Biopharma, Platform Technology |
| Competitors | Johnson & Johnson, Roche, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Moderna Therapeutics, Novavax +46 more (view full list) |
Looking for a particular Smart Immune employee's phone or email?
Karine Rossignol is the CEO and co founder of Smart Immune.
9 people are employed at Smart Immune.
Smart Immune is based in Paris, Île-de-France.